

Benzphetamine is harder to find than ever in 2026. Learn why pharmacies run out, what's behind the supply issues, and how to locate it near you.
If you've been prescribed Benzphetamine for weight loss and can't seem to find it at your local pharmacy, you're not alone. Patients across the country have been struggling to fill their prescriptions, and the problem doesn't seem to be going away in 2026.
In this article, we'll break down exactly what Benzphetamine is, why it's so difficult to find right now, and what you can do to get your medication filled.
Benzphetamine (brand names Didrex and Regimex) is a prescription weight-loss medication. It belongs to a class of drugs called sympathomimetic amine anorexiants — essentially, it's related to amphetamines but has a lower risk of abuse.
Benzphetamine works by stimulating the central nervous system, increasing the release of norepinephrine and dopamine in the brain. This helps suppress your appetite so you eat less. It's approved by the FDA as a short-term adjunct to diet and exercise for patients with a BMI of 30 or higher who haven't lost enough weight through lifestyle changes alone.
The medication comes as a 50 mg oral tablet and is classified as a Schedule III controlled substance by the DEA. This scheduling is important — and it's one of the reasons it can be hard to find.
Because Benzphetamine is a Schedule III controlled substance (an amphetamine derivative), the DEA sets strict limits on how much can be manufactured each year. These are called production quotas.
The broader stimulant medication shortage that began in 2022–2023 was largely driven by DEA quota limitations. While Benzphetamine hasn't been the primary target of shortages, the ripple effects of tighter quotas on all amphetamine-class drugs have reduced availability across the board. DEA quota changes in 2024–2025 continue to affect supply into 2026.
Unlike widely prescribed medications with dozens of generic makers, Benzphetamine has a small number of manufacturers. The brand-name version, Didrex, is made by Patheon Puerto Rico, and only a handful of generic manufacturers produce Benzphetamine Hydrochloride tablets. When even one manufacturer has a production issue, the impact on overall supply is significant.
Many pharmacies — especially large chains — make stocking decisions based on demand. Because Benzphetamine is prescribed far less frequently than medications like Phentermine (its more popular cousin), pharmacies often don't keep it on their shelves. If your pharmacy doesn't regularly stock it, they'll need to special-order it — which can take days or even weeks if distributors are also running low.
The weight-loss medication market has exploded in recent years, driven by the popularity of GLP-1 drugs like Ozempic and Wegovy. This increased attention has also boosted demand for older, more affordable options like Benzphetamine. More prescriptions competing for limited supply means more patients showing up to empty shelves.
If you're struggling to fill your prescription, here are some practical steps:
For more detailed tips, see our full guide: How to find Benzphetamine in stock near you.
Finding Benzphetamine in 2026 is harder than it should be, but it's not impossible. The shortage is driven by a combination of DEA quotas, limited manufacturers, pharmacy stocking habits, and rising demand. By using the right tools and being proactive with your pharmacist and doctor, you can improve your chances of getting your prescription filled.
If cost is also a concern, check out our guide on how to save money on Benzphetamine — prices can range widely, and discount cards can bring the cost down significantly.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.